Pura Vida Investments’s AstraZeneca AZN Stock Holding History

Pura Vida Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-87,500	Closed	-$9.6M	–	202
2022 Q3	$9.6M	Buy	87,500 +6,086	+7%	+$772K	0.56%	52
2022 Q2	$10.8M	Buy	81,414 +66,414	+443%	+$8.71M	0.62%	44
2022 Q1	$1.99M	Buy	+15,000	New	+$1.8M	0.06%	161
2021 Q4	–	Sell	-25,000	Closed	-$3M	–	240
2021 Q3	$3M	Buy	+25,000	New	+$2.91M	0.09%	171

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's AZN Position: Q4 2022 in Review

Pura Vida Investments sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 87,500 shares — an estimated $9.6M sold.

Pura Vida Investments first reported a position in AZN in Q3 2021 and held it in 4 quarters. The position peaked at $10.8M in Q2 2022. 1,062 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

Pura Vida Investments reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 87,500 AstraZeneca shares in Q4 2022, an estimated $9.6M.
Pura Vida Investments first reported a position in AstraZeneca in Q3 2021 and held it in 4 quarters.
Pura Vida Investments's AstraZeneca position peaked at $10.8M in Q2 2022.
1,062 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.